Stock KH6 NEWAMSTERDAM PHARMA COMPANY N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders NewAmsterdam Pharma Company N.V. Deutsche Boerse AG

Equities

KH6

NL00150012L7

Delayed Deutsche Boerse AG
Other stock markets
 03:15:01 2024-07-02 EDT 		5-day change 1st Jan Change
18.2 EUR +7.06% Intraday chart for NewAmsterdam Pharma Company N.V. +4.60% +85.71%
06-11 NewAmsterdam Pharma Gets Another US Patent Extending IP Protection for Obicetrapib Until July 2043 MT
06-10 Transcript : NewAmsterdam Pharma Company N.V. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 10:40 AM

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
NewAmsterdam Pharma Names Juliette Audet Chief Business Officer
MT
Newamsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer
CI
Newamsterdam Pharma Insider Sold Shares Worth $4,095,234, According to a Recent SEC Filing
MT
NewAmsterdam Pharma Company N.V. Announces Board Changes
CI
NewAmsterdam Pharma Appoints Ian Somaiya as Chief Financial Officer
MT
NewAmsterdam Pharma Company N.V. Appoints William ?BJ" Jones as Chief Commercial Officer
CI
NewAmsterdam Pharma Company Appoints Janneke van der Kamp to its Board of Directors
CI
NewAmsterdam Pharma Company N.V. Appoints John W. Smither as Independent Director
CI
NewAmsterdam Pharma Names David Topper CFO
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NAMS Stock
  4. KH6 Stock
  5. News NewAmsterdam Pharma Company N.V.
  6. Insiders